Apr 24, 2026 10:08AM

Apr 13, 2026 06:06AM

Dec 9, 2025 06:06AM

Aug 17, 2025 07:30PM

Jul 10, 2025 09:31AM

Jul 10, 2025 09:30AM

Jun 9, 2025 07:30PM Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

66,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All